{
  "docId": "019de075-ab2a-73e5-980a-7d480707ba09",
  "docSlug": "340a1966b9939070959283ec1665bfbf",
  "documentTitle": "Kymera | Investor Presentation Deck | 60 slides",
  "authorId": "kymera",
  "authorName": "Kymera",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 60,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "TPD stands for Targeted Protein Degradation.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-ab2a-73e5-980a-7d480707ba09/5",
  "deckHref": "/decks/019de075-ab2a-73e5-980a-7d480707ba09",
  "deckJsonHref": "/decks/019de075-ab2a-73e5-980a-7d480707ba09.json",
  "deckAnchorHref": "/decks/019de075-ab2a-73e5-980a-7d480707ba09#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.35
      },
      "kind": "list",
      "text": "Successfully Applied TPD to Unmet Needs Outside of Oncology: Reported clinical impact in complex inflammatory diseases such as HS and AD",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0119f920-6f67-48af-ac05-bc1e3334136f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.69
      },
      "kind": "list",
      "text": "Kymera is Building Franchises in Both Immunology and Oncology: Focus is on areas of high unmet needs and large commercial opportunity, in targets with clear degrader rationale",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2e43d06c-7859-418c-b0a7-cd4a0485f549",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.18
      },
      "kind": "list",
      "text": "Validated Platform and Discovery Engine: Demonstrated predictable translation of PK, PD and Safety in 3 oncology and immunology programs",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5fc2125b-8b7b-4680-a008-c2764ff16ce8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.52
      },
      "kind": "list",
      "text": "Demonstrated TPD Can Lead to Differentiated Clinical Activity Compared to Small Molecule Inhibitors: Initial KT-474 data in HS and AD validates Kymera’s unique target selection strategy",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8f452ff7-c7b9-40be-9b62-cff09fbadc12",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "What Our Recent Accomplishments Mean for Kymera and TPD",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f2ac9c56-a269-447c-9c5c-d392796a5180",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Story Moments",
      "slug": "story-moments",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "1cda3578-19d0-41d3-a81c-d6c87a36d7ae",
      "evidence": "title and headline emphasizing key points",
      "confidence": 0.6
    },
    {
      "name": "Storytelling: the three headline reasons",
      "slug": "three-reasons",
      "agent": "storyteller",
      "layer": "slide",
      "matchId": "65ff032f-f3b2-4604-b105-1df2b9d22211",
      "evidence": "list/bullet points highlighting recent accomplishments",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 8,
      "from": 4,
      "beatId": "3ff1231c-28d5-4168-9951-2cb642678691",
      "arcName": "AIDA",
      "arcSlug": "aida",
      "beatName": "Interest",
      "beatSlug": "aida-interest",
      "evidence": "The traction and solution slides build interest in Kymera's technology and pipeline",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 8,
      "from": 4,
      "name": "Logic Chain",
      "slug": "01-logic-chain",
      "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
      "matchId": "f0707415-95aa-42c7-886c-374c15b46870",
      "evidence": "The deck opens a loop on Kymera's approach and closes it with a clear explanation",
      "position": 0,
      "objective": "What is Kymera's approach to TPD?",
      "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
      "confidence": 0.7,
      "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}